Susquehanna International Group, LLP Kronos Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.75 - $1.49 $1,050 - $2,086	1,400 Added 6.93%	21,600 $27,000
Q3 2023 Nov 14, 2023	BUY	$1.23 - $2.25 $24,846 - $45,450	20,200 New	20,200 $26,000
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $17,856 - $42,656	12,400 New	12,400 $20,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $19,032 - $45,872	6,100 Added 6.88%	94,700 $345,000
Q1 2022 May 16, 2022	BUY	$6.26 - $14.42 $554,636 - $1.28 Million	88,600 New	88,600 $641,000

886K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $50M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.